6505--Melatonin Tablets Effective 09/15/26 - 09/14/27

The Department of Veterans Affairs, through its National Acquisition Center, has awarded a requirements contract for the supply of melatonin tablets and capsules in 1mg, 3mg, and 5mg dosages with a one-year base period and four one-year option periods, effective from September 15, 2026, to September 14, 2027. The contract, issued under solicitation number 36E79726R0015, is an unrestricted commercial item procurement governed by FAR Part 12 and awarded using the Lowest Price Technically Acceptable methodology, where technical acceptability is a pass/fail threshold and award is determined solely by the lowest evaluated price. The supply is intended to meet the needs of multiple federal agencies including the VA, DoD, BOP, IHS, and FHCC, with estimated annual usage of 35,394 bottles of 1mg, 1,363,153 bottles of 3mg, and 439,142 bottles of 5mg melatonin tablets. Packaging and labeling requirements are strictly defined: products must be in plastic, child-proof safety-cap bottles of 60 or 90 count with a minimum 120cc volume and cylindrical shape meeting specific dimensional thresholds; each bottle must carry a unique 11-digit NDC number, FDA-compliant labeling per GS1 and HIBCC standards, and a legible barcode on the immediate container with a Data Matrix 2D barcode on the lowest saleable package to meet DSCSA requirements. Labels must allow VA over-labeling, maintain visibility of expiration and lot numbers, and include human-readable numbers adjacent to barcodes for BCMA system fallback. All manufacturing must comply with current Good Manufacturing Practices (cGMP), and offerors must provide stability testing certification. The contract mandates submission of physical samples for evaluation and requires active SAM.gov registration with correct UEI and CAGE codes. Payments will flow through designated government Prime Vendors such as McKesson and Cardinal Health, with no direct payment from the government, and assignment of payment rights is prohibited. Subcontracting plans are required if the contract value exceeds $900,000, and compliance with VA, FDA, and federal regulations is mandatory throughout performance. The contracting officer for this award is Deborah Fassl, based in Hines, Illinois, and offers were due by March 26, 2026.